|

How Psychedelics Helped GoDaddy Founder Bob Parsons Treat His PTSD



Bob Parsons is an American entrepreneur and a Marine Corps veteran who suffered all his life from PTSD incurred while serving in Viet Nam. It wasn’t until he read HOW TO CHANGE YOUR MIND by Michael Pollan, that he became inspired by the potential in psychedelics, in conjunction with more mainstream counseling practices, to alleviate suffering from trauma commonly associated with military service.

In this interview, Parsons and Psychedelic Spotlight CEO David Flores discuss how psychedelics in combination with therapy can help heal not only veterans suffering from with treatment resistant PTSD but also prisoners and ex-cons who have been unjustly locked away.

They also discuss the necessity of trained therapists and psychedelic guides in order to ensure patient safety, and what the future holds for psychedelic medicines.

The message continues to be plain and simple, and heard now from voices with no reason to embellish on their beliefs: psychedelics help heal trauma and can save lives.

#Psychedelics #PTSD #GoDaddy

source

Similar Posts

  • HUGE News on Compass Pathways (CMPS) Patents [ + Updates on MINDMED (MMED/MMEDF) ENBI, CYBN & MYCOF]

    In today’s episode of “This Week in Psychedelic Stocks”, we have News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Cybin (CYBN) & Mydecine (MYCO / MYCOF).

    I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the FTSE so that MMED / MMEDF news is not in this episode. However, this wasn’t the only big news this week. Compass Pathways (CMPS) received not one but 2 new patents and surely, some of you might find this news worth discussing…

    We will cover the latest developments in the field writ large.
    This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.

    Timestamps:
    0:00 – Intro
    0:55 – Psilocybin to treat OCD?
    5:28 – The Psychedelic Industry worth $300 Billion by 2027?
    8:24 – MindMed stock news ( MMED / MMEDF / MMQ)
    11:39 – Compass Pathways stock news ( CMPS)
    15:07 – Entheon Biomedical Corp stock news ( ENBI / ENTBF )
    19:25 – Cybin stock news ( CYBN / CLXPF )
    22:52 – Mydecine stock new ( MYCO / MYCOF )

    So that’s it for This Week in Psychedelic Stocks fellow psychedelic investors!

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​#CompassPathways​​ #Entheon

  • Riley Cote – From NHL Enforcer to Psychedelic Therapy Advocate

    On this episode of the Psychedelic Spotlight Podcast, our host David Flores catches up with former Philadelphia Flyer and NHL enforcer, Riley Cote who in recent years has become one of the most prominent and outspoken advocates for psychedelics and psychedelic-assisted therapy through his work with the Wake Network and RileyCote.com.